Elevated site urgencyFDA Class II

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31

cGMP deviations.

Agency
FDA Drug
Recall date
Apr 1, 2026
Status
Ongoing
Company
Wells Pharma of Houston LLC

1. What product was recalled?

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Quantity: 4975 syringes

Code or lot text: 120925302312764, Exp Date 04/09/2026, 123125302312879 Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026 020426302310243, Exp Date 06/06/2026.

LOT
010226302310003
LOT
010626302310007
LOT
010626302310008
LOT
05/05/2026
LOT
120925302312764
LOT
123125302312879 Exp Date
LOT
123125302312880
LOT
Exp Date 04/09/2026
LOT
Exp Date 05/05/2026
LOT
Exp Date 05/06/2026
LOT
Exp Date 05/08/2026
LOT
Exp Date 05/08/2026 020426302310243
LOT
Exp Date 06/06/2026.
RECALL-NUMBER
D-0507-2026

fentaNYL Citrate Injectable Solution in 0

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

Quantity: 150 syringes

Code or lot text: Lot 022326203650432; Exp Date 06/25/2026

LOT
Exp Date 06/25/2026
LOT
Lot 022326203650432
RECALL-NUMBER
D-0506-2026

fentaNYL Citrate injectable Solution in 0

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.

Quantity: 2940 IV Bags

Code or lot text: 120125202032701, Exp Date 04/01/2026; 122625202032857, Exp Date 04/25/2026; 122625202032862, Exp Date 04/28/2026, 122625202032863. Exp Date 04/28/2026; 122625202032864, Exp Date 04/28/2026; 122625202032865, Exp Date 04/28/2026, 011226202030062, Exp Date 05/14/2026, 011326202030776, Exp Date 05/15/2026; 011326202030077, Exp Date 05/15/2026, 011626202030111, Exp Date 05/20/2026, 011926202030122, Exp Date 05/21/2026; 011926202030123, Exp Date 05/21/2026, 012726202030159, Exp Date 05/28/2026, 020226202030200, Exp Date 06/04/2026, 020326202030216, Exp Date 06/05/2026, 020426202030234, Exp Date 06/06/2026, 02182202030398, Exp Date 06/20/2026.

LOT
011226202030062
LOT
011326202030077
LOT
011326202030776
LOT
011626202030111
LOT
011926202030122
LOT
011926202030123
LOT
012726202030159
LOT
020226202030200
LOT
020326202030216
LOT
020426202030234
LOT
02182202030398
LOT
120125202032701
LOT
122625202032857
LOT
122625202032862
LOT
122625202032863. Exp Date 04/28/2026
LOT
122625202032864
LOT
122625202032865
LOT
Exp Date 04/01/2026
LOT
Exp Date 04/25/2026
LOT
Exp Date 04/28/2026
LOT
Exp Date 05/14/2026
LOT
Exp Date 05/15/2026
LOT
Exp Date 05/20/2026
LOT
Exp Date 05/21/2026
LOT
Exp Date 05/28/2026
LOT
Exp Date 06/04/2026
LOT
Exp Date 06/05/2026
LOT
Exp Date 06/06/2026
LOT
Exp Date 06/20/2026.
RECALL-NUMBER
D-0504-2026

2. Is my exact product affected?

Compare every printed identifier. A matching value can indicate that your product is included.

3. What is the hazard?

cGMP deviations.

4. What should I do now?

Follow the FDA recall notice and contact the recalling company for current instructions.

5. Where was it sold or distributed?

Nationwide

6. Were injuries or illnesses reported?

No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.

7. What remedy is available?

Follow the FDA recall notice and contact the recalling company for current instructions.

8. Is the recall active or closed?

The source status is Ongoing. Recall Index urgency is elevated, which is a separate deterministic site label.

9. When was the information checked?

Last checked .

  1. created

10. Where is the official source?

Open the official FDA Drug source

Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.